Locacorten-Vioform

Known as: Locorten-Vioform, locacorten vioform 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1945-2018
012319452017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND AND OBJECTIVES Locacorten Vioform (Novartis UK) is frequently prescribed for otomycosis. Its component, Clioquinol… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2016
Review
2016
OBJECTIVES/HYPOTHESIS The goal of this systematic review was to compare the efficacy and ototoxicity of Locacorten-Vioform… (More)
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
2008
2008
OBJECTIVE To determine the expansile and absorptive properties of the expandable ear wick when tested with commonly prescribed… (More)
Is this relevant?
2001
2001
Seventy-two mycologically proven cases of otomycosis (38 males, 34 females) aged 8-80 years were investigated. Aspergillus niger… (More)
Is this relevant?
1983
1983
Ten antiprotozoal drugs were tested in vitro against four axenic strains of the intestinal parasite Blastocystis hominis… (More)
Is this relevant?
1979
1979
The percutaneous absorption of clioquinol from three different preparations for skin treatment (Vioform cream, Locacorten-Vioform… (More)
Is this relevant?
1977
1977
 
Is this relevant?
1975
1975
In a double-blind study involving 430 patients, Locacorten (0.02%)-Vioform (3%) cream was found to be highly effective in the… (More)
Is this relevant?
1966
1966
  • A Rongel
  • Boletim do Instituto de Puericultura e Pediatria…
  • 1966
 
Is this relevant?